VIDEO: Pacritinib safe with thrombocytopenia in myelofibrosisJune 12, 2015Lymphoma & Plasma Cell DisordersRare Diseases
CD8 cell dose predicts outcomes in allogeneic stem cell transplantation with reduced-intensity conditioningJune 8, 2015Lymphoma & Plasma Cell Disorders
Triple therapy added toxicity without survival benefit in multiple myelomaJune 8, 2015Lymphoma & Plasma Cell Disorders
VIDEO: Heavily pretreated multiple myeloma yields to novel antibodyJune 2, 2015Lymphoma & Plasma Cell Disorders
VIDEO: Rituximab-refractory indolent NHL yields to combo treatmentJune 1, 2015Lymphoma & Plasma Cell Disorders
Less intensive childhood cancer therapy reduces late toxicities, deathsJune 1, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPatient & Survivor Care
Novel antibody evokes responses in relapsed/refractory myelomaMay 31, 2015Lymphoma & Plasma Cell DisordersRare Diseases
GADOLIN: Combination improves PFS in rituximab-refractory indolent NHLMay 30, 2015Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Dexrazoxane Tx did not affect overall survival in pediatric leukemia and lymphomaMay 26, 2015Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Exercise may lower risk for non-Hodgkin’s lymphomaMay 1, 2015Lymphoma & Plasma Cell DisordersPreventive Care
Forgoing radiotherapy after chemo in early Hodgkin’s is close callApril 22, 2015Lymphoma & Plasma Cell Disorders
